Clinical trial
Pamidronate Administration in Breast Cancer Patients With Bone Metastases
NCT00128297
Study timeline
Study start (actual)2000-10-18Date precision: day
Registry last updated2023-03-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Neoplasm Metastasisunresolved
Interventions
PamidronateDRUG · verified · RxNorm: pamidronate
Sponsors & collaborators
Spanish Breast Cancer Research Grouplead sponsor
Novartiscollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00128297 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.